073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform

Detalles Bibliográficos
Autores principales: Langan, S., Smith, C., Collaborative, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672437/
http://dx.doi.org/10.1016/j.jid.2022.09.083
_version_ 1784832734373347328
author Langan, S.
Smith, C.
Collaborative, T.
author_facet Langan, S.
Smith, C.
Collaborative, T.
author_sort Langan, S.
collection PubMed
description
format Online
Article
Text
id pubmed-9672437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96724372022-11-18 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform Langan, S. Smith, C. Collaborative, T. J Invest Dermatol Article Published by Elsevier Inc. 2022-12 2022-11-18 /pmc/articles/PMC9672437/ http://dx.doi.org/10.1016/j.jid.2022.09.083 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Langan, S.
Smith, C.
Collaborative, T.
073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title_full 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title_fullStr 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title_full_unstemmed 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title_short 073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
title_sort 073 risk of severe covid-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the opensafely platform
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672437/
http://dx.doi.org/10.1016/j.jid.2022.09.083
work_keys_str_mv AT langans 073riskofseverecovid19outcomesassociatedwithimmunemediatedinflammatorydiseasesandimmunemodifyingtherapiesanationwidecohortstudyintheopensafelyplatform
AT smithc 073riskofseverecovid19outcomesassociatedwithimmunemediatedinflammatorydiseasesandimmunemodifyingtherapiesanationwidecohortstudyintheopensafelyplatform
AT collaborativet 073riskofseverecovid19outcomesassociatedwithimmunemediatedinflammatorydiseasesandimmunemodifyingtherapiesanationwidecohortstudyintheopensafelyplatform

Ejemplares similares